• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后风险标准化死亡率的操作人员变异性评估:来自 NCDR 的报告。

Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR.

机构信息

VA Puget Sound Health Care System, Seattle, Washington; Division of Cardiology, University of Washington, Seattle, Washington.

Duke Clinical Research Institute, Durham, North Carolina.

出版信息

JACC Cardiovasc Interv. 2017 Apr 10;10(7):672-682. doi: 10.1016/j.jcin.2016.12.019.

DOI:10.1016/j.jcin.2016.12.019
PMID:28385404
Abstract

OBJECTIVES

This study sought to determine variability and stability in risk-standardized mortality rates (RSMR) of percutaneous coronary intervention (PCI) operators meeting minimum case volume standards and identify differences in case mix and practice patterns that may account for RSMR variability.

BACKGROUND

RSMR has been suggested as a metric to evaluate the performance of PCI operators; however, variability of operator-level RSMR and the stability of this metric over time among the same operator are unknown.

METHODS

The authors calculated mean RSMRs for PCI operators with average annual volume of ≥50 cases in the National Cardiovascular Data Registry CathPCI Registry. Funnel plots were used to account for operator case volume. Demographic, clinical, and treatment variables of patients treated by operators with outlying high or low RSMRs (identified by RMSR greater than or less than 2 σ above or below the mean [analogous to 2 SD], respectively) were compared with nonoutlier operators. RMSR stability was assessed by calculating average annual operator RMSR during the study period and by determining if operators were consistently classified into RMSR categories in each year.

RESULTS

Between October 1, 2009, and September 30, 2014, a total of 2,352,174 PCIs were performed at 1,373 hospitals by 3,760 operators. Of these, 242 operators (6.5%) had RSMR >2 σ above the mean and 156 operators (4.1%) had RSMR >2 σ below the mean. Both high and low RSMR outlier operators treated patients with lower expected mortality risk, compared with nonoutlier operators. There was significant instability in annual operator RMSR during the study period.

CONCLUSIONS

There is significant variability in risk-standardized PCI mortality among U.S. operators meeting minimum volume standards that is not explained by case mix or procedure characteristics. Operator RMSR was unstable from year to year, thus limiting its utility as a sole performance measure for PCI quality.

摘要

目的

本研究旨在确定符合最低病例量标准的经皮冠状动脉介入治疗(PCI)术者的风险标准化死亡率(RSMR)的变异性和稳定性,并确定可能导致 RSMR 变异性的病例组合和实践模式差异。

背景

RSMR 已被提议作为评估 PCI 术者表现的指标;然而,术者层面的 RSMR 的变异性以及同一术者在不同时间点 RSMR 的稳定性尚不清楚。

方法

作者计算了国家心血管数据注册中心 CathPCI 注册中心中平均每年 PCI 病例量≥50 例的 PCI 术者的平均 RSMR。使用漏斗图来考虑术者的病例量。对 RSMR 偏高或偏低(定义为高于或低于平均值的 2σ[相当于 2 个标准差])的术者治疗的患者的人口统计学、临床和治疗变量与非异常术者进行比较。通过计算研究期间每个术者的平均年度术者 RSMR 以及确定术者是否在每年都被一致归类到 RSMR 类别中,来评估 RSMR 的稳定性。

结果

2009 年 10 月 1 日至 2014 年 9 月 30 日期间,共有 1373 家医院的 3760 名术者进行了 2352174 例 PCI。其中,242 名术者(6.5%)的 RSMR 高于平均值的 2σ,156 名术者(4.1%)的 RSMR 低于平均值的 2σ。与非异常术者相比,RSMR 偏高和偏低的术者治疗的患者的预期死亡率风险较低。在研究期间,术者每年的 RSMR 变化显著。

结论

符合最低病例量标准的美国 PCI 术者的风险标准化 PCI 死亡率存在显著的变异性,无法用病例组合或手术特征来解释。术者的 RSMR 年复一年地不稳定,因此限制了其作为 PCI 质量的唯一绩效衡量指标的使用。

相似文献

1
Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR.经皮冠状动脉介入治疗后风险标准化死亡率的操作人员变异性评估:来自 NCDR 的报告。
JACC Cardiovasc Interv. 2017 Apr 10;10(7):672-682. doi: 10.1016/j.jcin.2016.12.019.
2
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.术者手术量与经皮冠状动脉介入治疗后长期结局的关系。
Circulation. 2019 Jan 22;139(4):458-472. doi: 10.1161/CIRCULATIONAHA.117.033325.
3
When high-volume PCI operators in high-volume hospitals move to lower volume hospitals-Do they still maintain high volume and quality of outcomes?当高容量医院的高容量 PCI 操作人员转移到低容量医院时,他们是否仍然保持高容量和高质量的结果?
Catheter Cardiovasc Interv. 2018 Oct 1;92(4):644-650. doi: 10.1002/ccd.27403. Epub 2017 Oct 31.
4
Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.美国顶尖医院和非顶尖医院行经皮冠状动脉介入治疗的适宜性和结局。
JACC Cardiovasc Interv. 2018 Feb 26;11(4):342-350. doi: 10.1016/j.jcin.2017.10.042. Epub 2017 Nov 12.
5
Procedural Volume and Outcomes After Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery DiseaseReport From the National Clinical Data (J-PCI Registry).经皮冠状动脉介入治疗无保护左主干冠状动脉疾病的操作量和结局:来自全国临床数据(J-PCI 注册研究)的报告。
J Am Heart Assoc. 2020 May 5;9(9):e015404. doi: 10.1161/JAHA.119.015404. Epub 2020 Apr 29.
6
Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.美国经皮冠状动脉介入治疗(PCI)的疗效与手术特征及术者手术量的关系
J Am Coll Cardiol. 2017 Jun 20;69(24):2913-2924. doi: 10.1016/j.jacc.2017.04.032.
7
Are Higher Operator Volumes for Unprotected Left Main Stem Percutaneous Coronary Intervention Associated With Improved Patient Outcomes?: A Survival Analysis of 6724 Procedures From the British Cardiovascular Intervention Society National Database.更高的无保护左主干经皮冠状动脉介入术(ULMCA)手术量与改善患者预后相关吗?:来自英国心血管介入学会国家数据库的 6724 例手术的生存分析。
Circ Cardiovasc Interv. 2020 Jun;13(6):e008782. doi: 10.1161/CIRCINTERVENTIONS.119.008782.
8
Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry®.介入心脏病学领域的女性:来自美国国家心血管数据注册库®的经皮冠状动脉介入治疗实践模式及女性操作者结局的最新情况
Catheter Cardiovasc Interv. 2016 Mar;87(4):663-8. doi: 10.1002/ccd.26118. Epub 2015 Aug 10.
9
The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings.极高风险病例对医院经风险调整后的经皮冠状动脉介入治疗死亡率评级的影响。
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):10-6. doi: 10.1016/j.jcin.2014.07.025. Epub 2014 Dec 10.
10
Impact of Institutional and Operator Volume on Short-Term Outcomes of Percutaneous Coronary Intervention: A Report From the Japanese Nationwide Registry.机构和术者量对经皮冠状动脉介入治疗短期结局的影响:来自日本全国登记的报告。
JACC Cardiovasc Interv. 2017 May 8;10(9):918-927. doi: 10.1016/j.jcin.2017.02.015.

引用本文的文献

1
Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among US Hospitals.美国医院中ST段抬高型心肌梗死患者接受经皮冠状动脉介入治疗可能性的差异
J Am Heart Assoc. 2025 Mar 4;14(5):e038317. doi: 10.1161/JAHA.124.038317. Epub 2025 Feb 19.
2
Evaluation of Peer Review of Percutaneous Coronary Intervention Operator Performance.经皮冠状动脉介入治疗术操作者表现的同行评审评估
Circ Cardiovasc Qual Outcomes. 2025 Jan;18(1):e011159. doi: 10.1161/CIRCOUTCOMES.124.011159. Epub 2025 Jan 3.
3
Government Regulation and Percutaneous Coronary Intervention Volume, Access and Outcomes: Insights From the Washington State Cardiac Care Outcomes Assessment Program.
政府监管与经皮冠状动脉介入治疗量、可及性和结局:来自华盛顿州心脏护理结局评估计划的见解。
J Am Heart Assoc. 2022 Sep 6;11(17):e025607. doi: 10.1161/JAHA.122.025607. Epub 2022 Sep 3.
4
Peer evaluation and feedback for invasive medical procedures: a systematic review.同行评议和反馈在有创医疗操作中的应用:系统综述。
BMC Med Educ. 2022 Jul 29;22(1):581. doi: 10.1186/s12909-022-03652-9.
5
Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.医院在评估急性心肌梗死患者基于疾病的死亡率与手术死亡率方面的表现。
JAMA Cardiol. 2020 Jul 1;5(7):765-772. doi: 10.1001/jamacardio.2020.0753.
6
Association Between Current and Future Annual Hospital Percutaneous Coronary Intervention Mortality Rates.当前和未来年度医院经皮冠状动脉介入治疗死亡率之间的关联。
JAMA Cardiol. 2019 Nov 1;4(11):1077-1083. doi: 10.1001/jamacardio.2019.3221.
7
Characteristics of the Quality Improvement Content of Cardiac Catheterization Peer Reviews in the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.退伍军人事务临床评估、报告和跟踪计划中心脏导管检查同行评议质量改进内容的特征。
JAMA Netw Open. 2019 Aug 2;2(8):e198393. doi: 10.1001/jamanetworkopen.2019.8393.
8
Coronary Revascularization in High-Risk Stable Patients With Significant Comorbidities: Challenges in Decision-Making.合并严重共病的高危稳定型患者的冠状动脉血运重建:决策中的挑战
Curr Treat Options Cardiovasc Med. 2019 Feb 9;21(1):5. doi: 10.1007/s11936-019-0706-7.
9
Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists.纽约州介入心脏病学家的经皮冠状动脉介入治疗后 30 天死亡率与教育和认证变量之间的关联。
Circ Cardiovasc Interv. 2018 Sep;11(9):e006094. doi: 10.1161/CIRCINTERVENTIONS.117.006094.
10
Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo.经皮冠状动脉介入治疗结果的公众报告:超越现状。
JAMA Cardiol. 2018 Jul 1;3(7):635-640. doi: 10.1001/jamacardio.2018.0947.